Bnp Paribas Asset Management Holding S.A. Vertex Pharmaceuticals Inc Transaction History
Bnp Paribas Asset Management Holding S.A.
- $37.3 Billion
- Q1 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 392,013 shares of VRTX stock, worth $175 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
392,013
Previous 389,657
0.6%
Holding current value
$175 Million
Previous $157 Million
21.15%
% of portfolio
0.51%
Previous 0.39%
Shares
31 transactions
Others Institutions Holding VRTX
# of Institutions
1,829Shares Held
233MCall Options Held
1.38MPut Options Held
1.08M-
Capital World Investors Los Angeles, CA28.5MShares$12.7 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$10.5 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.51 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.48 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.26 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $114B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...